Austrian Cholesterol Screening And Treatment II (Act II)

Trial Profile

Austrian Cholesterol Screening And Treatment II (Act II)

Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2015

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms ACT-II
  • Sponsors Merck & Co
  • Most Recent Events

    • 21 Mar 2012 Company (Merck & Co) added as trial sponsor as reported by
    • 29 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top